Cardiovascular diseases are constantly increasing worldwide, and particularly in low-income countries. Amongst cardiovascular diseases, bradyarrhythmia is a true burden to the health care system due to its increasing prevalence with age and the cost of pacemaker implantation. As limited data is available on this subject in Cameroon, we conducted a
PACE 4 LIFE: One Pacemaker, One Life Saved
CRENC – IeDEA: Leadership and Scientific Writing Training
Scientific productivity and research in Africa for Africa is limited and unequally distributed across the continent. Capacity strengthening, developing skills in scientific writing and leadership training , have been postulated to mitigate this trend. It is on this premise that the Clinical Research Education, Networking and Consultancy (CRENC) through Pr.
50th Ten-Day International Teaching Seminar on Cardiovascular Disease Epidemiology and Prevention
The 50thTen-Day International Teaching Seminar on Cardiovascular Disease Epidemiology and Prevention held in Goa, India from June 17 to June 29 2018. CRENC was represented at this prestigious 10 days teaching seminar by Dr. Sih Colette. Dr. Sih is a fourth year resident in Internal Medicine at the Baptist Institute of
GCHF CAMEROON UPDATE- 24TH JULY 2018
As at this date Cameroon has recruited 1301 patients out of the 17 411 patients already recruited into the Global Congestive Heart Failure Registry worldwide. This is remarkable as Cameroon is the leading African country in the GCHF. Recruitment into the main study has officially been closed for Cameroon since
IeDEA Stakeholders’ Meeting: Mbalmayo, Yaounde
Purpose: To provide the Cameroon IeDEA stakeholders with an overview of the IeDEA study implementation in Cameroon as well as present the Cameroon IeDEA study 4-year strategic plan. Present at the meeting were representatives from: Albert Einstein College of Medicine, USA Clinical Research Education Networking and Consultancy (CRENC) Directorate of
Global Congestive Heart Failure Registry (GCHF) in Cameroon
Heart failure (HF) is a rapidly increasing disease worldwide and results in major morbidity, mortality and costs. No global HF study has been performed that documents demographics, socioeconomic and clinical factors, diagnostic and management patterns, etiology, biomarkers, co-morbidities, treatments, quality of life, barriers to care and outcomes in all parts
CREOLE Study in Cameroon
Reducing blood pressure to target levels is a major priority in preventing clinical events in hypertension. Although there are many possible combinations of BP-lowering therapies, the best combination for the black population is still a subject of debate. Furthermore, current guideline recommendations are inconsistent and conflicting for black patients. CREOLE stands
The INVICTUS Trial in Cameroon
Stroke is a devastating and decapitating outcome of Atrial Fibrillation (AF). AF affects 1-2% of the general population and it’s the most frequently encountered arrhythmia in clinical practice. Although any valvular pathology can be related to AF, stenotic left-sided valvular lesions (and in particular rheumatic heart disease) have the highest
Cervical Cancer Study in Cameroon
Human immunodeficiency virus-infected (HIV[+]) women have a several-fold increased risk of invasive cervical cancer (ICC) as well as increased risk of cervical pre-cancer. In low- and middle income countries (LMICs), ICC is the 1st or 2nd most common cause of cancer and cancer-related death in women. Rates of ICC and
IeDEA Project in Cameroon
The overall goal of the IeDEA study is to use secondary clinical, laboratory and epidemiologic data from HIV-infected patients in various regions to answer HIV/AIDS and other related co-morbidities research questions that cannot be answered with existing individual cohorts in each country. The IeDEA research consortium makes it possible to
